These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of STAT3 and NF-κB activations by S-nitrosylation in multiple myeloma. Kim J; Choi S; Saxena N; Singh AK; Singh I; Won JS Free Radic Biol Med; 2017 May; 106():245-253. PubMed ID: 28232202 [TBL] [Abstract][Full Text] [Related]
23. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986 [TBL] [Abstract][Full Text] [Related]
24. Altholactone Inhibits NF-κB and STAT3 Activation and Induces Reactive Oxygen Species-Mediated Apoptosis in Prostate Cancer DU145 Cells. Jiang C; Masood M; Rasul A; Wei W; Wang Y; Ali M; Mustaqeem M; Li J; Li X Molecules; 2017 Feb; 22(2):. PubMed ID: 28178219 [TBL] [Abstract][Full Text] [Related]
25. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868 [TBL] [Abstract][Full Text] [Related]
27. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Lee JH; Chiang SY; Nam D; Chung WS; Lee J; Na YS; Sethi G; Ahn KS Cancer Lett; 2014 Apr; 345(1):140-8. PubMed ID: 24333736 [TBL] [Abstract][Full Text] [Related]
28. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. Takada Y; Ichikawa H; Badmaev V; Aggarwal BB J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072 [TBL] [Abstract][Full Text] [Related]
29. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB. Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. Zheng L; Fu Y; Zhuang L; Gai R; Ma J; Lou J; Zhu H; He Q; Yang B Int J Cancer; 2014 Oct; 135(7):1721-32. PubMed ID: 24615207 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. Manni S; Brancalion A; Mandato E; Tubi LQ; Colpo A; Pizzi M; Cappellesso R; Zaffino F; Di Maggio SA; Cabrelle A; Marino F; Zambello R; Trentin L; Adami F; Gurrieri C; Semenzato G; Piazza F PLoS One; 2013; 8(9):e75280. PubMed ID: 24086494 [TBL] [Abstract][Full Text] [Related]
32. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905 [TBL] [Abstract][Full Text] [Related]
33. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932 [TBL] [Abstract][Full Text] [Related]
34. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation. Ni H; Zhao W; Kong X; Li H; Ouyang J Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922 [TBL] [Abstract][Full Text] [Related]
35. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Liang Y; Xu RZ; Zhang L; Zhao XY Acta Pharmacol Sin; 2009 Dec; 30(12):1659-65. PubMed ID: 19960011 [TBL] [Abstract][Full Text] [Related]
36. Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model. Siveen KS; Mustafa N; Li F; Kannaiyan R; Ahn KS; Kumar AP; Chng WJ; Sethi G Oncotarget; 2014 Feb; 5(3):634-48. PubMed ID: 24504138 [TBL] [Abstract][Full Text] [Related]
37. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Pandey MK; Sung B; Ahn KS; Aggarwal BB Mol Pharmacol; 2009 Mar; 75(3):525-33. PubMed ID: 19103760 [TBL] [Abstract][Full Text] [Related]
38. Antinflammatory and anticancer effects of terpenes from oily fractions of Teucruim alopecurus, blocker of IκBα kinase, through downregulation of NF-κB activation, potentiation of apoptosis and suppression of NF-κB-regulated gene expression. Guesmi F; Prasad S; Tyagi AK; Landoulsi A Biomed Pharmacother; 2017 Nov; 95():1876-1885. PubMed ID: 28968948 [TBL] [Abstract][Full Text] [Related]
39. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421 [TBL] [Abstract][Full Text] [Related]
40. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]